Prevalence, distribution, and clinical characteristics of hemangiosarcoma-associated skeletal muscle metastases in 61 dogs: A whole body computed tomographic study
- PMID: 30793807
- PMCID: PMC6430957
- DOI: 10.1111/jvim.15456
Prevalence, distribution, and clinical characteristics of hemangiosarcoma-associated skeletal muscle metastases in 61 dogs: A whole body computed tomographic study
Abstract
Background: Skeletal muscle metastases (SMMs) have been described sporadically in canine oncology.
Hypothesis/objectives: To determine the prevalence, localization, and clinical signs of SMMs associated with hemangiosarcoma (HSA) in a population of dogs presented for whole body computed tomography (CT).
Animals: Dogs with a histologically confirmed HSA and a tissue core specimen or fine needle aspirate of suspected metastatic lesions were included in the study.
Methods: Retrospective study. Dogs with a final diagnosis of visceral or muscular HSA that underwent whole body CT scan were enrolled in the study. Final diagnosis of primary tumor and SMMs was reached by histology, cytology, or both. Signalment, clinical signs, localization of the primary lesion, and metastases characteristics were reviewed.
Results: Sixty-one dogs met the inclusion criteria. Skeletal muscle metastases were detected in 15 dogs (24.6%) and all of these dogs had also metastases in ≥1 sites. Presence of SMMs was significantly higher in males but was not significantly related to age, neuter status, breed, localization, and dimensions of the primary tumor. Nine of 15 (60.0%) dogs with SMMs showed lameness or reluctance to move whereas these signs were not recorded in any of the 42 dogs without SMMs (P < .001).
Conclusion and clinical importance: Prevalence of SMMs in our population of dogs with HSA was higher in comparison to previous studies in the human and veterinary medical literature. Whole body CT is recommended for staging of dogs with HSA, because SMMs could be missed by clinical examination and traditional diagnostic imaging modalities.
Keywords: dogs; imaging; lameness; oncology.
© 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
Conflict of interest statement
Authors declare no conflict of interest.
Figures
References
-
- Thamm DH. Hemangiosarcoma In: Withrow SJ, Vail DM, eds. Withrow and MacEwen's Small Animal Clinical Oncology. St. Louis, MO: Saunders; 2013:679‐688.
-
- Hammond TN, Pesillo‐Crosby SA. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003–2005). J Am Vet Med Assoc. 2005;232:553‐558. - PubMed
-
- Cooper BJ, Valentine BA. Tumors of muscle In: Meuten DJ, ed. Tumors in Domestic Animals. 4th ed. Ames, IA: Iowa State Press; 2002:341‐359.
-
- Clifford CA, Mackin AJ, Henry CJ. Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med. 2000;14:479‐485. - PubMed
-
- Gruntzig K, Graf R, Boo G, Guscetti F, et al. Swiss Canine Cancer Registry 1955‐2008: occurrence of the most common tumour diagnoses and influence of age, breed, body size, sex and neutering status on tumour development. J Comp Pathol. 2016;155:156‐170. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
